Imagine walking into a grocery store where 83% of the shelf space is one brand of cereal. Not one category. One brand. There’s still a bread aisle and a produce section, technically, but they’ve been squeezed into a corner near the restrooms. That’s roughly the shape of US venture funding right now, and it changes what lands on my desk for review every week.
Through the first three quarters of 2026, AI companies captured 82.7% of all US venture deal value, per the Q3 2026 PitchBook-NVCA Venture Monitor. Total US deal value reached $515.8 billion through September, about 44% above the full-year record set in 2021. In July alone, AI companies took 67% of total capital, raising $13.08 billion across 196 companies. Crunchbase data published in April put Q1 AI funding around $242 billion globally, roughly 80% of all global venture funding for the quarter.
Those are big numbers, and most coverage treats them as a scoreboard. I’d rather treat them as a supply chain report, because that money turns into the tools I test.
Why a funding monoculture shows up in your tool choices
When one category absorbs nearly every dollar, three things happen to the software that reaches users.
- Free tiers get generous in ways the unit economics don’t support. A product with a fresh round can afford to give away inference that costs real money. That’s great until the round runs out and the pricing page quietly triples.
- Feature velocity outruns reliability. Capital rewards shipping. 196 companies raised in a single month, and a lot of them are racing the same roadmap. Polish is the first thing to get cut.
- Everything starts to look the same. I’ve reviewed four agent frameworks this quarter that differ mainly in logo and docs theme. When money chases one pattern, you get the same product with different onboarding flows.
The flip side is real too. Some of that capital bought genuine capability. Tooling that was unusable eighteen months ago now works, and works well enough that I’ve stopped recommending manual workarounds for a few categories. Concentration isn’t automatically waste.
The question I keep coming back to
Chamath Palihapitiya of Social Capital, who posted the 83% figure in mid-October, framed the concern as something other than circular revenue. He described it as a revenue quality problem: revenue that depends on venture money rather than independent customers paying for something they’d pay for anyway.
That framing is useful for anyone picking tools. I can’t audit a startup’s cap table, but I can usually tell whether a product has customers or has users who were handed credits. The signals are mundane. Does the product have a self-serve plan that someone would actually choose over the free tier? Are there case studies from companies outside the founder’s investor network? Does support respond like a business that needs to keep you, or like a team that’s measured on signups?
How I’m reviewing tools in this environment
My checklist has gotten more boring and more useful:
- Price the thing at real volume. Not the demo workload. Take your actual monthly token count and multiply. If the answer is absurd, the free tier is a marketing expense, not a plan.
- Check the export path before you commit. Can you get your prompts, evals, traces, and fine-tune data out in a format something else can read? This is the single best hedge against a vendor disappearing or pivoting.
- Prefer boring interfaces. Tools that speak standard APIs and standard file formats survive their vendors. Tools that invent proprietary abstractions take your work with them when they go.
- Discount the benchmarks. In a space this well-funded, benchmark numbers are a fundraising artifact as much as a product claim. Run your own tasks. Ten real examples from your workflow beat any leaderboard.
- Ask what happens at renewal. Teams flush with capital negotiate differently than teams eighteen months into a round. Get pricing commitments in writing where you can.
What this means if you’re building, not buying
If you’re a founder outside AI, the 82.7% figure confirms what you already suspected about your fundraising conversations. If you’re building AI tooling, the uncomfortable read is that a record-setting funding year is also a crowded one. Capital at this concentration doesn’t guarantee a market; it guarantees competition.
For the rest of us, the practical takeaway is less dramatic. A lot of money is flowing through a narrow pipe, and some of it is producing solid tools while some of it is producing demos with pricing pages. Telling those apart is the whole job. Test with your own data, keep your exit path open, and treat a big round as information about a company’s runway, not its quality.
🕒 Published: